NR3C2 and cancer: Specifically, in 9/10 cancer types, we observed that genes undergoing hypermethylation and underexpression were significantly (Fisher-test P < 0.05) more likely to map to the EC+MR signaling domain compared to the IC domain (Figure 2A).